Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Comment by deminimison Jul 19, 2018 1:00am
74 Views
Post# 28336721

RE:RE:RE:RE:RE:RE:RE:Mari > Emblem

RE:RE:RE:RE:RE:RE:RE:Mari > EmblemIf they aren’t dropping $50M on a greenhouse now they have no need to raise money this year unless they have some other big plans we don’t know about yet:

“During the three months ended March 31, 2018, the Company completed significant transactions to strengthen its cash position. In January 2018, the holders of convertible debt exercised their option to convert their debentures into common shares of the Company, resulting in a $15,000,000 reduction of debt. As at the date of this MD&A, after considering the purchase of units in Fire & Flower for $2,500,000, completed in April 2018, and capital expenditures incurred at the Woodslee Production Facility in the interim period, the Company had approximately $77,000,000 in cash and cash equivalents.
In the Company’s MD&A for the year ended December 31, 2017, the Company reported approximately $80,000,000 in cash and cash equivalents as at April 27, 2018 and described plans to utilize the funds as outlined below. The expected use of cash and cash equivalents remains consistent as of the date of this MD&A.”
     
<< Previous
Bullboard Posts
Next >>